These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 18079620)
1. [Advances in therapeutic strategies for multiple myeloma]. Miwa A Gan To Kagaku Ryoho; 2007 Dec; 34(13):2200-16. PubMed ID: 18079620 [TBL] [Abstract][Full Text] [Related]
2. Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma. Jagannath S; Dimopoulos MA; Lonial S Leuk Res; 2010 Sep; 34(9):1111-8. PubMed ID: 20472288 [TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma. Laubach J; Richardson P; Anderson K Annu Rev Med; 2011; 62():249-64. PubMed ID: 21090965 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and the current trends in multiple myeloma therapy. Dmoszyńska A Pol Arch Med Wewn; 2008 Oct; 118(10):563-6. PubMed ID: 19112817 [TBL] [Abstract][Full Text] [Related]
5. New drugs for myeloma. Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058 [TBL] [Abstract][Full Text] [Related]
6. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma. Laubach JP; Schlossman RL; Mitsiades CS; Anderson KC; Richardson PG Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778 [TBL] [Abstract][Full Text] [Related]
11. Current status of new drugs for the treatment of patients with multiple myeloma. Kenealy M; Prince HM Intern Med J; 2006 Dec; 36(12):781-9. PubMed ID: 17096741 [TBL] [Abstract][Full Text] [Related]